Effect of Yunnan baiyao aerosol treatment in subcutaneous hematoma after percutaneous coronary intervention
10.3760/j.issn.1674-2907.2014.22.048
- VernacularTitle:云南白药气雾剂治疗冠状动脉介入术后皮下血肿的效果
- Author:
Xiaoying CHEN
1
;
Shuluan SUN
;
Yuqin LI
;
Xiaohua HONG
;
Maozhen LIN
;
Jinghua XU
;
Lixuan HUANG
Author Information
1. 522000 广东省揭阳市人民医院心内科
- Keywords:
Yunnan baiyao aerosol;
Magnesium sulfate;
Percutaneous coronary intervention;
Subcutaneous hematoma
- From:
Chinese Journal of Modern Nursing
2014;20(22):2859-2861
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy of Yunnan baiyao aerosol treatment for patients undergone percutaneous coronary intervention ( PCI) with subcutaneous hematoma .Methods Seventy patients undergone PCI with subcutaneous hematoma were chosen as the research objects and divided into the observation group (35 cases) and the control group (35 cases) according to the order of odd or even number of patients enrolled . The patients in the observation group were treated with Yunnan baiyao aerosol plus Yunnan baiyao aerosol insurance solution, and those in the control group were treated with wet dressing of magnesium sulfate (50%). The treatment effects , healing time and degree of pain relief of the two groups were compared .Results The total efficiency of the observation group was 97.1%, which was significantly better than 85.7 of the control group (χ2 =11.893, P<0.05).The healing time of the observation group was (3.6 ±0.8) days, which was significantly shorter than (5.3 ±1.1) days in the control group (t=7.382, P<0.05).After 3 days of the treatment, 4 patients in the observation group and 13 patients in the control group had the severe pain .The difference of the degree of pain relief between the observation group and the control group was statistically significant ( Z =-7.432, P <0.05 ).Conclusions Yunnan baiyao aerosol treatment to subcutaneous hematoma after PCI can rapidly and safely relieve pain , swelling and stasis .It can be operated and accepted by patients easily .And it is worthy of clinical application .
